Business Trends
Diversification will be the key for 2006. Competition is fierce within the industry, as companies fight for consumer dollars.
Economic Trends
Once the financial picture of health, conditions today are bit more anemic. The industry is battling a maelstrom of bad press and consumer demands for lower prices.
Corporate/Plant Trends
As 2006 unfolds, Big Pharma will find itself increasingly sharing the stage with what is becoming Big Bio in its own right. Accommodating new drug development and manufacturing processes, Capital & Maintenance spending continues to grow in 2006, albeit slower than in years past.
Regulatory Trends
The FDA still finds itself in the harsh scrutiny of the public eye. Cause for the negative attention includes issues such as the unexpected resignation of its Commissioner, Lester Crawford, and charges of placing politics over science.
Outsourcing Trends
The total pharmaceutical and biotech outsourced market is currently pegged at $33 billion, with R&D outsourcing accounting for around 50% of the total market.
Technology Trends
The challenge of developing a more efficient vaccine manufacturing process remains an important challenge. Development of RFID and medical packaging technology continues as the industry seeks to safeguard both patients and products.
|
|
|
|
Spending Projections
2006 Spending Projections by Month
Capital Spending by Market Region
MRO Spending by Market Region
Plant Trends - Start-Ups & Closures
2006 Plant Start-Up Projections
Plant Analysis by Market Region
Plant Analysis by SIC Code
Economic Indicators
Leading Economic Indicators 
Historical Plant Trends
2005 Analysis by Market Region
Plant Start-Ups by Decade
Historical Economic Trends
Dow Jones Industrials
Nasdaq Composite
S&P 500
Unemployment
Gross Domestic Product
Factory Workers
Factory Output
|
Home
